SBIR-STTR Award

An Intramedullary Device for Distraction Osteogenesis
Award last edited on: 6/17/22

Sponsored Program
STTR
Awarding Agency
NIH : NIAMS
Total Award Amount
$99,967
Award Phase
1
Solicitation Topic Code
846
Principal Investigator
John Dawson

Company Information

Novus Orthopaedics LLC

705 Collins Trace Court
Nashville, TN 37221
   (615) 343-8391
   N/A
   N/A

Research Institution

Vanderbilt University

Phase I

Contract Number: 1R41AR044312-01A2
Start Date: 9/30/98    Completed: 9/29/00
Phase I year
1998
Phase I Amount
$99,967
This proposal seeks to develop a commercially-available and completely internal intramedullary (IM) nail which, when fixed to a broken for osteotomized bone, can promote distraction osteogenesis in humans. The device will be non-invasively powered by an external power system and will be precisely controlled by a computer. This new type of implantable nail for leg lengthening does not rely upon external fixation, transcutaneous cables or wires. It will provide a more comfortable and potentially safer method of limb lengthening over current technology. A prototype device has been tested and built. The protocol of Phase II animal trails will be based upon the results of bench testing of an existing prototype which will be further developed and designed to fit canine femorae in Phase I. PROPOSED COMMERCIAL APPLICATION: Phase I of this proposal is the first step toward a commercially- available, completely internal, intramedullary device for distraction osteogenesis. This implant will replace contemporary external fixators for limb lengthening procedures. This implant possesses the unique potential to sense bone stiffness and provide the clinician with a way to monitor the progress of bone regeneration. Using a feed-back control system, implant actuation (lengthening and oscillation) could be regulated by the bone stiffness desired

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----